PIPELINE

Pipeline

Pipeline table
Pipeline Target Indication Discovery Pre-clinical Phase 1 Phase 2 Phase 3
MFC0101
(BBB-permeable) 		Glioblastoma
37%
Solid Tumors
30%
Brain Metastases
20%
MFC0102
(Non-BBB-permeable) 		MASH
15%
Solid Tumors
15%
MFC0103 (BBB-permeable) Alzheimer's Disease
10%
MFC0201 Glioblastoma, Solid Tumors
9%
MFC0301 Glioblastoma, Solid Tumors
13%